Revolver Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$762K
- Investors
-
7
Revolver Therapeutics General Information
Description
Developer of peptide-based drug discovery technology designed to identify and develop next-generation therapeutics for cancer treatment. The company's platform utilizes patented constrained peptide screening technology to rapidly evaluate millions of peptide candidates and identify functional inhibitors targeting transcription factors, enabling pharmaceutical researchers and oncology-focused drug development organizations to access novel therapeutic compounds that address previously undruggable cancer targets through a more efficient and targeted discovery process.
Contact Information
Website
www.revolvertherapeutics.comCorporate Office
- Innovation Centre University Of Bath Claverton Down
- Bath BA2 7AY
- England, United Kingdom
Corporate Office
- Innovation Centre University Of Bath Claverton Down
- Bath BA2 7AY
- England, United Kingdom
Revolver Therapeutics Timeline
Revolver Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 06-Jul-2026 | $762K | Completed | Generating Revenue | ||
| 3. Seed Round | 15-Nov-2024 | Completed | Generating Revenue | |||
| 2. Grant | 28-Aug-2024 | $712K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 08-Feb-2023 | Completed | Generating Revenue |
Revolver Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Revolver Therapeutics Signals
Revolver Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| QantX | Venture Capital | Minority | ||
| Future Planet Capital | Venture Capital | Minority | ||
| O2h Ventures | Venture Capital | Minority | ||
| UK Innovation & Science Seed Fund | Venture Capital | Minority | ||
| Innovate UK | Government |
Revolver Therapeutics FAQs
-
When was Revolver Therapeutics founded?
Revolver Therapeutics was founded in 2023.
-
Where is Revolver Therapeutics headquartered?
Revolver Therapeutics is headquartered in Bath, United Kingdom.
-
What is the size of Revolver Therapeutics?
Revolver Therapeutics has 4 total employees.
-
What industry is Revolver Therapeutics in?
Revolver Therapeutics’s primary industry is Drug Discovery.
-
Is Revolver Therapeutics a private or public company?
Revolver Therapeutics is a Private company.
-
What is the current valuation of Revolver Therapeutics?
The current valuation of Revolver Therapeutics is .
-
What is Revolver Therapeutics’s current revenue?
The current revenue for Revolver Therapeutics is .
-
How much funding has Revolver Therapeutics raised over time?
Revolver Therapeutics has raised $956K.
-
Who are Revolver Therapeutics’s investors?
QantX, Future Planet Capital, O2h Ventures, UK Innovation & Science Seed Fund, and Innovate UK are 5 of 7 investors who have invested in Revolver Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process